TEVs containing miR-23b derived from mesenchymal bone marrow cancer stem cells (CSC) can induce cancer dormancy via downregulation of the MARCKS gene that mediates breast cancer cells’ differentiation into CSCs through the Wnt-β-catenin pathway [134,135]. This evidence concerns the gene MARCKS and cancer.